Agenus Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
3.50
0.59
(20.27%)
Volume:
3,182,163
52 week range:
1.38 - 19.69
Market Cap:
95.959M
Company Description:
Agenus Inc. discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer.